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Deﬁ ning Comorbidity: Implications for 
Understanding Health and Health Services
 ABSTRACT
Comorbidity is associated with worse health outcomes, more complex clinical 
management, and increased health care costs. There is no agreement, however, 
on the meaning of the term, and related constructs, such as multimorbidity, mor-
bidity burden, and patient complexity, are not well conceptualized. In this article, 
we review defi nitions of comorbidity and their relationship to related constructs. 
We show that the value of a given construct lies in its ability to explain a particu-
lar phenomenon of interest within the domains of (1) clinical care, (2) epidemiol-
ogy, or (3) health services planning and fi nancing. Mechanisms that may underlie 
the coexistence of 2 or more conditions in a patient (direct causation, associated 
risk factors, heterogeneity, independence) are examined, and the implications for 
clinical care considered. We conclude that the more precise use of constructs, as 
proposed in this article, would lead to improved research into the phenomenon 
of ill health in clinical care, epidemiology, and health services.
Ann Fam Med 2009;7:357-363. doi:10.1370/afm.983.
INTRODUCTION
Health care increasingly needs to address the management of indi-viduals with multiple coexisting diseases, who are now the norm rather the exception.1 In the United States, about 80% of Medi-
care spending is devoted to patients with 4 or more chronic conditions, 
with costs increasing exponentially as the number of chronic conditions 
increases.2 This realization is responsible for a growing interest on the part 
of practitioners and researchers in the impact of comorbidity on a range of 
outcomes, such as mortality, health-related quality of life, functioning, and 
quality of health care.3,4
Attempts to study the impact of comorbidity are complicated by the 
lack of consensus about how to deﬁ ne and measure the concept.3 Related 
constructs, such as multimorbidity, burden of disease, and frailty are often 
used interchangeably. There is an emerging consensus that internationally 
accepted deﬁ nitions are needed to move the study of this topic forward.3-5
Our purpose is to inform thinking in the research community by 
reviewing how comorbidity has been conceptualized in the literature and 
proposing a more precise use of terminology. In doing so, we review and 
discuss the mechanisms that may underlie the coexistence of 2 or more 
conditions in a patient, and we consider the implications of this coex-
istence for clinical care. As little is yet known about how patients with 
multiple conditions view their illness6,7 or how their perspective relates to 
professional constructs, the meaning of comorbidity will be examined only 
from the perspective of health care professionals.
REVIEWING THE CONCEPT OF COMORBIDITY
We searched the literature for available deﬁ nitions of the concept of 
comorbidity. Given the lack of speciﬁ city for standard search strategies 
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(a PubMed search in MEDLINE, including solely the 
Medical Subject Heading term “comorbidity” retrieved 
more than 25,000 records in the last 10 years), we used 
a structured search based upon previous strategies8,9 
 (Supplemental Appendix, available online as supple-
mental data at http://www.annfammed.org/cgi/
content/full/7/4/357/DC1), combined with a snow-
ball method that has proved efﬁ cient and reliable.10,11
Several deﬁ nitions have been suggested for comor-
bidity based on different conceptualizations of a single 
core concept: the presence of more than 1 distinct 
condition in an individual. Although always used as a 
person-level construct, 4 major types of distinctions 
are made: (1) the nature of the health condition, (2) the 
relative importance of the co-occurring conditions, (3) 
the chronology of presentation of the conditions, and 
(4) expanded conceptualizations.
Nature of the Health Condition
The nature of the conditions that co-occur have vari-
ously included diseases,8,12 disorders,13 conditions,4,5,8,12 
illnesses,14 or health problems.15 Some of these terms and 
concepts can be linked to classiﬁ cation systems, such as 
the International Classiﬁ cation of Diseases (ICD), the Diagnos-
tic and Statistical Manual of Mental Disorders (DSM), or the 
International Classiﬁ cation of Primary Care (ICPC), but the 
same is not possible for other terms and concepts, mak-
ing it difﬁ cult to use them in a reproducible manner.
Differentiating the nature of conditions is critical to 
the conceptualization of comorbidity, because simul-
taneous occurrence of loosely deﬁ ned entities may 
signal a problem with the classiﬁ cation system itself.16,17 
For example, some would argue that depression and 
anxiety are not separate entities but part of a spectrum, 
and, if so, patients with both should not be classiﬁ ed as 
having comorbidity.
The Relative Importance of the Conditions
Comorbidity is most often deﬁ ned in relation to a 
speciﬁ c index condition,18 as in the seminal deﬁ nition 
of Feinstein: “Any distinct additional entity that has 
existed or may occur during the clinical course of a 
patient who has the index disease under study.”12 The 
question of which condition should be designated the 
index and which the comorbid condition is not self-evi-
dent and may vary in relation to the research question, 
the disease that prompted a particular episode of care, 
or of the specialty of the attending physician. A related 
notion is that of complication, a condition that coexists 
or ensues, as deﬁ ned in the Medical Subject Head-
ings (MeSH)-controlled vocabulary maintained by the 
National Library of Medicine (NLM).
Multimorbidity has been increasingly used to refer to 
“the co-occurrence of multiple chronic or acute diseases 
and medical conditions within one person” without any 
reference to an index condition.6 Dual diagnosis in psy-
chiatry would be a particular example of multimorbidity, 
where 2 distinct disorders co-exist without any implicit 
ordering, eg, severe mental illness and substance abuse. 
Proponents of the concept of multimorbidity tend to 
focus on primary care, a setting where the identiﬁ cation 
of an index disease is often neither obvious nor useful.19
Chronology
Time span and sequence are the relevant consider-
ations. The ﬁ rst refers to the span of time across which 
the co-occurrence of 2 or more conditions is assessed. 
This concept may either be implicit or explicit in 
requiring that the various clinical problems co-occur 
at the same point in time. Synchronous occurrence has 
not always been the focus in the study of co-occurring 
mental health conditions, however, where there has 
been a considerable interest in disorders co-occurring 
across a period of time but not necessarily at the same 
time (Figure 1a).11 
A distinct but related issue is the sequence in which 
comorbidities appear, which may have important 
implications for genesis, prognosis, and treatment. 
Patients with established diabetes who receive a new 
diagnosis of major depression may be very different 
from patients with major depression who are later have 
Figure 1. Chronologic aspects of comorbidity .
a Time span
Point in time
Period of time
b Sequence
Each block represents the duration of a different comorbid disease. Two comor-
bid diseases can either be present at the same point in time (vertical arrow), or 
occur within a given time period without being simultaneously present at any 
given point in that period (horizontal arrow) (a). Irrespective of the selected 
time span, the sequence in which the diseases appear is of particular interest in 
the study of etiological association (b).
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diabetes diagnosed, although from a cross-sectional 
perspective, both may be viewed as patients with dia-
betes and depression (Figure 1b).
Expanded Conceptualizations: 
Morbidity Burden and Patient Complexity
Comorbidity has also been used to convey the notion 
of burden of illness or disease,20 deﬁ ned by the total 
burden of physiological dysfunction21 or the total 
burden of types of illnesses having an impact on an 
individual’s physiologic reserve.4 This concept is linked 
to its impact on patient-reported outcomes (including 
functioning)22 and hence to a related construct in the 
ﬁ eld of geriatrics, namely, frailty.23
Various approaches have been taken to character-
ize the combined burden of prespeciﬁ ed diseases or 
conditions as a single measure on a scale.24 The Charl-
son Index is one of the most widely used indices, and a 
recent review identiﬁ ed a dozen others, including the 
Cumulative Illness Rating Scale (CIRS), the Index of 
Coexisting Disease (ICED), and the Kaplan Index.24 
Other summary measures have focused on the stratiﬁ ca-
tion or classiﬁ cation of patients into groups according to 
diseases and conditions, age, and sex. Examples include 
Adjusted Clinical Groups (ACGs),21 Diagnosis-Related 
Groups (DRGs),25 and Healthcare Resource Groups 
(HRGs).26 All these aim to take not only the presence 
but also the severity of different 
diseases into account. Their pri-
mary purpose is to link diagnoses 
with their impact on the consump-
tion of health care resources or, 
alternatively, to compare the mix 
of cases seen by different clinicians 
while maintaining some broader 
understanding of the complexity 
of co-occurring diseases.27
Finally, a newly emerging 
construct is that of patient com-
plexity. This acknowledges that 
morbidity burden is inﬂ uenced 
not only by health-related char-
acteristics, but also by socioeco-
nomic, cultural, environmental, 
and patient behavior characteris-
tics.28,29 From a clinical perspec-
tive, it will be obvious that disease 
factors interact with social and 
economic factors to make clinical 
management more or less chal-
lenging, time-consuming, and 
resource intensive. Capturing and 
measuring this complexity, how-
ever, remains a challenge.
INTEGRATING THE DIFFERENT CONSTRUCTS
Each construct illuminates a different aspect of mor-
bidity. Consider a 60-year-old woman with diabetes 
mellitus, hypertension, and depression, who is from 
an ethnic minority, has a low literacy in English, and 
who cares for her stroke-limited husband. Her men-
tal health professional, focusing on the depression, 
would consider her diabetes mellitus and hypertension 
as comorbidities. Her primary care physician might 
describe her as having multimorbidity, giving equal 
attention to her diabetes mellitus, hypertension, and 
depression. Her morbidity burden, as measured by 
any of the available measures, would be determined by 
the presence of the different diseases and taking their 
relative severity into account. Finally, her complexity 
as a patient would also be shaped by her cultural back-
ground, her proﬁ ciency in English, and by her personal 
situation as a whole, including living conditions and not 
least her role as caretaker for her husband (Figure 2).
DIFFERENT DEFINITIONS 
FOR DIFFERING USES
There are 3 main research areas in which it is impor-
tant to apply and measure these constructs: (1) clinical 
care, (2) epidemiology and public health, and (3) health 
service planning and ﬁ nancing.
Figure 2. Comorbidity constructs. 
Patient’s complexity
Non–health-related individual attributes
Morbidity burden
Sex Age Frailty
Other health-related individual attributes
Multimorbidity
Disease 1 (index)
Comorbidity (of index disease)
Disease 2 Disease n
Comorbidity: presence of additional diseases in relation to an index disease in one individual. 
Multimorbidity: presence of multiple diseases in one individual. 
Morbidity burden: overall impact of the different diseases in an individual taking into account their severity. 
Patient’s complexity: overall impact of the different diseases in an individual taking into account their sever-
ity and other health-related attributes.
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In clinical research, the construct of choice will be 
determined by its ability to inform patient management. 
Although the notion of patient complexity is relevant to 
all aspects of care, the construct of comorbidity, with its 
emphasis on an index disease, may be particularly useful 
in specialist care, which has a strong orientation toward 
a single (index) disease. Multimorbidity and morbidity 
burden may prove better constructs for primary care, 
where the focus is explicitly on the patient as a whole 
without privileging any one condition. In this context, 
research into how patients themselves conceptualize 
comorbidity or multimorbidity and the implications for 
effective self-management should be a priority.
From an epidemiological and public health perspec-
tive, the key issue is the genesis of concurrent diseases. 
Approaches to the study of genesis and pathways will 
be reviewed in the next section, but the constructs of 
comorbidity (index disease) and multimorbidity will 
both be of interest in this context. They allow for 
measurement approaches based on counts (presence or 
absence), thereby providing the necessary information 
for estimating incidence and prevalence rates. Con-
sideration of chronology in the development of condi-
tions will be of particular importance in this context.
From a health services research and policy per-
spective, coexisting diseases need consideration when 
deciding on the allocation of resources. Estimates of 
future costs will not be well represented as a sum of the 
costs of the separate illnesses and may well be either 
greater or less than that sum depending on the nature 
of the interactions among the coexisting illnesses. 
Overall burden of disease and patient complexity pro-
vide a better conceptualization of the problem for this 
purpose. Here the use of summary measures may offer 
new opportunities for quantifying and monitoring pop-
ulation health and its impact on health care utilization 
and cost and so assist in health care planning. A sys-
tematic review of existing indices to determine which is 
best ﬁ t for this purpose would prove valuable.
RELATIONSHIPS BETWEEN 
COMORBID DISEASES
The coexistence of 2 or more diseases in the same indi-
vidual raises 2 major clinical questions: whether there is 
an underlying common etiological pathway, and/or what 
is their impact on clinical care. For simplicity, we will dis-
cuss the situations in which there are only 2 conditions.
Pathways to Comorbidity
A number of different factors determine the overall 
health of populations and individuals, ranging from 
genetic and biologic characteristics of the individual to 
the political and policy context.30 They all play a role 
in the etiology of any particular disease; hence, they are 
also expected to play a role in co-occurring diseases. 
Intuitively, diseases would be expected to cluster in an 
individual if they shared a common pattern of inﬂ uences 
or if the resilience or vulnerability of the individual was 
altered. But other reasons may explain this clustering.
There are 3 main ways in which different diseases 
may be found in the same individual: chance, selec-
tion bias, or by 1 or more types of causal association. 
Comorbidity that occurs by chance or selection bias is 
without causal linkage but is still important because it 
may lead to erroneous assumptions about causality.
Two diseases can co-occur simply by chance. Con-
sider a population with type 2 diabetes, which affects 
about 4% of individuals, and eczema which inde-
pendently affects about 5%. By chance alone, 0.2% 
(0.04*0.05 = 0.002) of the population would have both 
eczema and diabetes. An association of importance 
would therefore need to show a signiﬁ cant departure 
from this estimate.
Selection bias is an alternative explanation. In his 
original description of the selection bias affecting 
patients attending health services, Berkson observed 
decades ago that disease clusters appeared more fre-
quently in patients seeking care than in the general 
population,31 almost certainly because patients seeking 
care were more likely to acquire a diagnosis irrespec-
tive of what it was. This type of bias can be avoided 
using community samples rather than patients attend-
ing health services.
Four models of genuine etiological association 
between conditions have been described: direct causa-
tion, associated risk factors, heterogeneity, and inde-
pendence (Figure 3).32
In the direct causation model, the presence of 1 dis-
ease is directly responsible for another. From a clinical 
perspective, this model would also include the situation 
in which treatment for 1 disease caused another con-
dition (eg, a anticoagulant given for atrial ﬁ brillation 
causing a gastrointestinal hemorrhage).
In the associated risk factors model, the risk fac-
tors for 1 disease are correlated with the risk factor for 
another disease, making the simultaneous occurrence 
of the diseases more likely. For example, smoking and 
alcohol consumption are correlated; the former is a risk 
factor for chronic obstructive pulmonary disease and 
the later a risk factor for liver disease, making it more 
likely the 2 diseases will occur together.
By contrast, in the heterogeneity model, disease 
risk factors are not correlated, but each is capable of 
causing diseases associated with the other risk factor 
(eg, tobacco and age are independent risk factors for a 
number of malignancies and cardiovascular diseases).
In the independence (distinct disease) model, the 
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simultaneous presence of the 
diagnostic features of the co-
occurring diseases actually corre-
sponds to a third distinct disease. 
For example, the co-occurrence 
of hypertension and chronic ten-
sion headache might both be due 
to pheochromocytoma.
These 4 models are not nec-
essarily mutually exclusive and 
have yet to be applied extensively 
to the study of comorbidity. 
All models have, however, been 
successfully tested by means of 
simulation and proved empirically 
valid in the assessment of selected 
comorbidities.33
Comorbidity and Its Impact 
on Disease Management
The need to classify comorbid 
health problems in terms of their 
relevance to clinical management 
was recognized early,12 and a 
number of classiﬁ cation systems 
have been suggested (Table 1). 
These systems are useful and 
widely reﬂ ected in clinical care 
practice. For example, ischemic 
heart disease, cardiovascular risk 
factors (hypertension, hyper-
cholesterolemia), and diabetes 
are commonly managed within 
the same cardiovascular clinics 
in primary care because they 
share important aspects of disease 
management. Drawing together 
patients who have similar clinical 
management needs may be efﬁ -
cient, but doing so runs the risk 
of concealing the wider range of 
ways in which speciﬁ c diseases 
may interact in relation to diag-
nosis, prognosis, treatment, and 
management (including self-man-
agement) or outcomes. Even for 
the same pair of comorbid condi-
tions (eg, diabetes and chronic 
pulmonary disease), some inter-
ventions can be antagonistic (eg, 
consider the effect of hypogly-
cemic drugs and corticosteroids 
on blood glucose), others may 
be agonistic (physical activity), 
Figure 3. Etiological models of comorbid diseases. 
For ease of presentation, we have only considered 2 different diseases, and 2 corresponding risk factors. Each 
model relies on the interaction between either diseases or risk factors. The relationships described above apply 
both to protective factors and to risk factors.32
Risk Factor 1 Risk Factor 2
Disease 1 Disease 2
No etiological association: there 
is no etiological association between 
the diseases.
Direct causation
One of the diseases may cause the 
other, eg, Disease 1 (D1) = diabetes 
mellitus, Disease 2 (D2) = cataracts.
Associated risk factors
The risk factors for each disease 
are correlated, eg, Risk Factor 
1 (RF1) = smoking; Risk Factor 
2 (RF2) = alcohol; D1 = chronic 
pulmonary obstructive diseaase; 
D2 = liver cirrhosis.
Independence
The presence of the diagnostic 
features of each disease is actually 
due to a third distinct disease, 
eg, D1 = hypertension; D2 = tension 
headache; D3 = pheochromocytoma.
Heterogeneity
The risk factors for each diseases 
are not correlated, but each one 
of them can cause either diseae, 
eg, RF1 = smoking; RF2 = age; 
D1 = ischemic heart disease; 
D2 = lung cancer.
Risk Factor 1 Risk Factor 2
Disease 1 Disease 2
Risk Factor 3
Disease 3
Risk Factor 1 Risk Factor 2
Disease 1 Disease 2
Risk Factor 1 Risk Factor 2
Disease 1 Disease 2
Risk Factor 1 Risk Factor 2
Disease 1 Disease 2
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and others may be neutral. In Table 2 we show possible 
interactions between diabetes mellitus and a range of 
different comorbid clinical entities. Improved under-
standing of such interactions among comorbid diseases 
is important to improving clinical care.
Interactions among chronic diseases have been 
a particular focus of interest because they may have 
far-reaching effects on both health and health care.37 
But it is no less true that any acute or subacute condi-
tion may appreciably affect the management of any 
other disease.38 A minor acute injury to the right leg, 
for example, may impair the mobility of a person, thus 
affecting the management and control of her diabetes; 
it may also make apparent the presence of osteoarthri-
tis of the left knee that so far had been compensated.
DISCUSSION
Two main limitations of the present work need to be 
acknowledged. First, although the methods for search-
ing the literature were valid, we cannot be certain 
that all relevant constructs and deﬁ nitions have been 
identiﬁ ed. Second, our focus has been on professional 
concepts of comorbidity. Although we have occasion-
ally addressed the patient’s perspective, we have not 
consistently done so throughout the work. In particular, 
patients’ perspectives on the ways in which multiple 
conditions affect their health, well-being, and clinical 
care are highly relevant to the constructs of comorbidity 
considered here but have not been explicitly addressed.
We have deﬁ ned the various constructs underpin-
ning the co-occurrence of distinct diseases (comor-
bidity of an index disease, multimorbidity, morbidity 
burden, and patient complexity), described how these 
are interrelated, and shown how different constructs 
might best be applied to 3 different research areas (clini-
cal care, epidemiology, health services). Future research 
would beneﬁ t by using the explicit deﬁ nitions for the 
constructs outlined here in conjunction with established 
disease classiﬁ cation systems, such as ICD-10, ICPC, or 
DSM-IV. Doing so would enhance both the precision 
and generalizability of ﬁ ndings, leading to improved 
understanding of the causes of co-occurring diseases 
and their consequences for health service providers 
and planners. More research into patients’ perspectives 
on the ways in which multiple conditions affect their 
Table 1. Impact of Comorbidity on Clinical Care: Overview of Classifi cation Systems
Author Classifi cation Defi nition 
Kaplan 
et al12,34,35
Diagnostic comorbidity “An associated disease [whose]…manifestations can simulate those of the index disease” 
(eg, pneumonia and pulmonary infarction)
Prognostic comorbidity Diseases “[in relation to an index disease] graded according to their anticipated effects on 
therapy and life expectancy [as]”
Cogent “Comorbid ailments expected to impair a patient’s long-term survival” (eg, recent severe stroke)
Noncogent “Other ailments” (eg, congestive heart failure or myocardial infarction more than 6 months old)
Angold et al16 Homotypic comorbidity “Disorders within a diagnostic grouping” (eg, major depression and dysthymia)
Heteroptypic comorbidity “Disorders from different diagnostic groupings” (eg, major depression and conduct disorder)”
Piette and 
Kerr36
Concordant comorbidity “[Diseases as] parts of the same pathophysiologic risk profi le and more likely to share the same 
management and are more likely to be the focus of the same disease management plan” (eg, 
type 2 diabetes mellitus and hypertension)
Discordant comorbidity Diseases that are “not directly related in either pathogenesis or management and do not share an 
underlying predisposing factor” (eg, type 2 diabetes mellitus and irritable bowel syndrome)
Table 2. Comorbidity Interactions Using Diabetes as an Example of a Disease That Can Affect 
the Diagnosis, Treatment, or Prognosis of a Second Disease
Impact on Clinical Activity Examples
Diagnosis
Made easier by coexisting disease Most diabetic patients undergo regular fundus examinations, making the diagnosis of unre-
lated retinal disease, such as age-related macular retinopathy, more likely
Made more diffi culty by a coexisting disease Diabetic patients may have altered pain sensation, thereby interfering with and making more 
diffi cult the diagnosis of coronary heart disease
Treatment
Indicated for existing and coexisting disease Physical exercise as recommended for a patient with chronic obstructive pulmonary disease 
can have a benefi cial effect on diabetes
Antagonistic effect on coexisting disease Corticosteroids prescribed for chronic obstructive pulmonary disease in the same patient will 
have an antagonistic effect on the diabetes treatment
Prognosis
Positively modifi ed by a coexisting disease Mortality associated with diabetes is increased in the presence of peripheral vascular disease
Not affected by a coexisting disease Diabetes is unaffected by the presence of hypothyroidism
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health, well-being, and clinical care is needed to comple-
ment the professional perspective adopted here and 
ensure that care is truly patient centered.
To read or post commentaries in response to this article, see it 
online at http://www.annfammed.org/cgi/content/full/7/4/357.
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